Jiangxi Boya Bio-Pharmaceutical Co., Ltd is principally engaged in the research, development, production and distribution of blood products. The Company's major products include human albumin, freeze-drying intravenous injection human immune globulin, human immune globulin, hepatitis B human human immune globulin, hydrophobia human immune globulin, as well as human fibrinogen, among others. The Company's albumin products are mainly used in the therapy of tumor, liver disease and diabetes mellitus. The Company's immune globulin products are primarily used in the therapy of immunity diseases and infection diseases. The Company distributes its products mainly in domestic markets.